198 related articles for article (PubMed ID: 23555990)
21. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
Khanbolooki S; Nawrocki ST; Arumugam T; Andtbacka R; Pino MS; Kurzrock R; Logsdon CD; Abbruzzese JL; McConkey DJ
Mol Cancer Ther; 2006 Sep; 5(9):2251-60. PubMed ID: 16985059
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
Yang JM; Jang JY; Jeon YK; Paik JH
J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
[TBL] [Abstract][Full Text] [Related]
23. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.
Cillessen SA; Meijer CJ; Ossenkoppele GJ; Castricum KC; Westra AH; Niesten P; Muris JJ; Nijdam HF; van der Hem KG; Flens M; Hooijberg E; Oudejans JJ
Br J Haematol; 2006 Aug; 134(3):283-93. PubMed ID: 16848771
[TBL] [Abstract][Full Text] [Related]
24. Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma.
Hussain AR; Ahmed M; Ahmed S; Manogaran P; Platanias LC; Alvi SN; Al-Kuraya KS; Uddin S
Free Radic Biol Med; 2011 Apr; 50(8):978-87. PubMed ID: 21215312
[TBL] [Abstract][Full Text] [Related]
25. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
Davis RE; Brown KD; Siebenlist U; Staudt LM
J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
27. Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen.
Lam LT; Davis RE; Ngo VN; Lenz G; Wright G; Xu W; Zhao H; Yu X; Dang L; Staudt LM
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20798-803. PubMed ID: 19104039
[TBL] [Abstract][Full Text] [Related]
28. Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis.
Velho-Pereira R; Kumar A; Pandey BN; Jagtap AG; Mishra KP
Cell Biol Int; 2011 Oct; 35(10):1025-9. PubMed ID: 21557727
[TBL] [Abstract][Full Text] [Related]
29. Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.
Cobourne-Duval MK; Taka E; Mendonca P; Soliman KFA
J Neuroimmunol; 2018 Jul; 320():87-97. PubMed ID: 29759145
[TBL] [Abstract][Full Text] [Related]
30. Thymoquinone inhibits growth of human medulloblastoma cells by inducing oxidative stress and caspase-dependent apoptosis while suppressing NF-κB signaling and IL-8 expression.
Ashour AE; Ahmed AF; Kumar A; Zoheir KM; Aboul-Soud MA; Ahmad SF; Attia SM; Abd-Allah AR; Cheryan VT; Rishi AK
Mol Cell Biochem; 2016 May; 416(1-2):141-55. PubMed ID: 27084536
[TBL] [Abstract][Full Text] [Related]
31. Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3.
Park JE; Kim DH; Ha E; Choi SM; Choi JS; Chun KS; Joo SH
Chem Biol Interact; 2019 Oct; 312():108799. PubMed ID: 31433961
[TBL] [Abstract][Full Text] [Related]
32. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672
[TBL] [Abstract][Full Text] [Related]
33. Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species.
Koka PS; Mondal D; Schultz M; Abdel-Mageed AB; Agrawal KC
Exp Biol Med (Maywood); 2010 Jun; 235(6):751-60. PubMed ID: 20511679
[TBL] [Abstract][Full Text] [Related]
34. R-roscovitine sensitizes anaplastic thyroid carcinoma cells to TRAIL-induced apoptosis via regulation of IKK/NF-kappaB pathway.
Festa M; Petrella A; Alfano S; Parente L
Int J Cancer; 2009 Jun; 124(11):2728-36. PubMed ID: 19230027
[TBL] [Abstract][Full Text] [Related]
35. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.
Milhollen MA; Traore T; Adams-Duffy J; Thomas MP; Berger AJ; Dang L; Dick LR; Garnsey JJ; Koenig E; Langston SP; Manfredi M; Narayanan U; Rolfe M; Staudt LM; Soucy TA; Yu J; Zhang J; Bolen JB; Smith PG
Blood; 2010 Sep; 116(9):1515-23. PubMed ID: 20525923
[TBL] [Abstract][Full Text] [Related]
36. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
37. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
Ng WK; Yazan LS; Ismail M
Toxicol In Vitro; 2011 Oct; 25(7):1392-8. PubMed ID: 21609759
[TBL] [Abstract][Full Text] [Related]
38. Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth
Anastasiadou E; Seto AG; Beatty X; Hermreck M; Gilles ME; Stroopinsky D; Pinter-Brown LC; Pestano L; Marchese C; Avigan D; Trivedi P; Escolar DM; Jackson AL; Slack FJ
Clin Cancer Res; 2021 Feb; 27(4):1139-1149. PubMed ID: 33208342
[TBL] [Abstract][Full Text] [Related]
39. Thymoquinone, extract from Nigella sativa seeds, protects human skin keratinocytes against UVA-irradiated oxidative stress, inflammation and mitochondrial dysfunction.
Liang J; Lian L; Wang X; Li L
Mol Immunol; 2021 Jul; 135():21-27. PubMed ID: 33857815
[TBL] [Abstract][Full Text] [Related]
40. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model.
Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM
Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]